Cybersecurity
IoT security: We are keeping consumers safe from cyber threats
A collaboration convened by the World Economic Forum has formed a global consensus for baseline IoT security measures to protect consumers.
- Headquarters
- United Kingdom
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative medicines and improving access to them. Its therapy areas cover oncology, rare diseases and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology. It has 11 R&D centres in five countries and 28 manufacturing sites across 16 countries. AstraZeneca sells its medicines to more than 130 countries and its main disease area medicines (excluding the vaccine) impact more than 100 million patient lives each year. In 2021, total revenue was $37.4 billion and $9.7 billion was invested in science and R&D.
Impact
2 articles from AstraZeneca
Forum Institutional
From mitigation to adaptation: 3 lessons for leaders putting health at the heart of climate action
The health sector must take action to mitigate its impact and help health systems adapt to increasing burdens. These initiatives show what can be achieved.
Forum Institutional
Urgency, innovation and partnership: applying lessons from COVID-19 to tackle the climate
Among the most important lessons learned during the pandemic is that public-private partnerships on a truly global scale can deliver against the odds.
Podcasts
Top book recommendations of 2022: Leaders reveal books that changed and inspired them
What’s inspired, informed, delighted and impressed the top leaders in business and civil society? In this second annual book recommendation episode, learn the top books recommended by CEO...
Health and Healthcare Systems
Lessons that made AstraZeneca's Leif Johansson a better leader
With a career that spans nearly 5 decades in science and technology -- one that includes time at AstraZeneca during its history making effort to deliver billions of vaccines to countries ...
AstraZeneca contributors
Françoise Bartoli
Vice President, Head of Europe and Canada Region, Oncology Business
Michel Demaré
Chair of the Board
Ruud Dobber
President, BioPharmaceuticals Business Unit; Executive Vice-President
Nitin Kapoor
Vice President BioPharmaceuticals International and Frontier Markets
Sir Mene Pangalos
Executive Vice-President, Biopharmaceutical Research and Development
Iskra Reic
Executive Vice-President, Vaccines and Immune Therapies Unit
Pascal Soriot
Executive Director and Chief Executive Officer
Juliette White
Vice-President, Global Safety, Health and Environment (SHE) and SustainabilityRelated Centres
Centre for Advanced Manufacturing and Supply Chains
The Centre for Advanced Manufacturing and Supply Chains is enabling more resilient, sustainable and inclusive manufacturing ecosystems and supply chains.
Centre for Health and Healthcare
The Centre for Health and Healthcare is identifying and scaling up solutions for more resilient, efficient, and equitable healthcare systems.
Centre for Nature and Climate
The Centre for Nature and Climate is accelerating net-zero climate action, regenerates food, water and ocean systems, and promotes circular economies.
Centre for the Fourth Industrial Revolution
The Centre for the Fourth Industrial Revolution is advancing the application of human-centred and society-serving technologies.